Classic Pyoderma Gangrenosum — Clinical Trials

MONDO:00352352 active·1 recruitingLast updated: Mar 22, 2026, 11:44 AM

Trial Landscape

Classic Pyoderma Gangrenosum has an emerging clinical trial program, driven by drug treatment.

Recruiting

Active Trials

By Approach

Drug Treatment2

By Phase

Phase 2

Phase 3

Sponsor Types

Academic/Other1Industry1

Top Sponsors

Boehringer Ingelheim

Trial Locations

China2 trials

United States1 trial

Argentina1 trial

Australia1 trial

Austria1 trial

Belgium1 trial

Brazil1 trial

Canada1 trial

Finland1 trial

France1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

2 Trials

Phase 3Recruiting

NCT06624670

A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum

Sponsor:Boehringer Ingelheim

United StatesStarted: Feb 2025Est. completion: Feb 2028Updated: Mar 2026

Phase 2Not Yet Recruiting

NCT07337564

A Clinical Study Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Ulcerative Pyoderma Gangrenosum

Sponsor:Shandong First Medical University

ChinaStarted: Feb 2026Est. completion: Jun 2028Updated: Jan 2026

Stay informed about clinical trials for Classic Pyoderma Gangrenosum.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 22, 2026 at 11:44 AM